Magan T, Pradeep T, Tuluc M, Bilyk J, Milman T
Saudi J Ophthalmol. 2022; 35(3):209-216.
PMID: 35601855
PMC: 9116086.
DOI: 10.4103/SJOPT.SJOPT_96_21.
Katzendorn O, Peters I, Dubrowinskaja N, Tezval H, Faraj Tabrizi P, von Klot C
BMC Cancer. 2021; 21(1):444.
PMID: 33882870
PMC: 8061065.
DOI: 10.1186/s12885-021-08172-1.
Cimadamore A, Cheng L, Scarpelli M, Massari F, Mollica V, Santoni M
Transl Androl Urol. 2021; 10(3):1506-1520.
PMID: 33850785
PMC: 8039604.
DOI: 10.21037/tau-20-1150.
Ortiz-Rey J, Fachal C, Juaneda-Magdalena L, Munoz-Martin M, Reparaz-Andrade A, Teijeira S
Virchows Arch. 2021; 479(1):57-67.
PMID: 33447899
DOI: 10.1007/s00428-021-03018-4.
Dey P, Kundu A, Han S, Kim K, Park J, Yoon S
Biomolecules. 2020; 10(9).
PMID: 32878322
PMC: 7565513.
DOI: 10.3390/biom10091260.
Integrative Analysis of lncRNAs in Kidney Cancer to Discover A New lncRNA () as A Therapeutic Target for Staphylococcal Enterotoxin Gene.
Safarpour-Dehkordi M, Doosti A, Jami M
Cell J. 2020; 22(Suppl 1):101-109.
PMID: 32779439
PMC: 7481890.
DOI: 10.22074/cellj.2020.6996.
A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma.
Wu G, Wang Q, Xu Y, Li Q, Cheng L
Aging (Albany NY). 2020; 12(14):14933-14948.
PMID: 32688345
PMC: 7425493.
DOI: 10.18632/aging.103553.
The putative tumour suppressor microRNA-145, repressed by c-jun, modulates clear cell renal cell carcinoma aggressiveness by repressing ROCK1.
Ding Z, Zhang X, Qiao Z, Li H, Ma Q, Liu X
Int J Clin Exp Pathol. 2020; 11(1):138-145.
PMID: 31938095
PMC: 6957973.
Trends in Renal-Cell Carcinoma Incidence and Mortality in the United States in the Last 2 Decades: A SEER-Based Study.
Saad A, Gad M, Al-Husseini M, Ruhban I, Sonbol M, Ho T
Clin Genitourin Cancer. 2018; 17(1):46-57.e5.
PMID: 30391138
PMC: 6348014.
DOI: 10.1016/j.clgc.2018.10.002.
VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney.
Wang L, Zhang Y, Chen Y, Skala S, Al-Ahmadie H, Wang X
Am J Surg Pathol. 2018; 42(12):1571-1584.
PMID: 30285995
PMC: 7903805.
DOI: 10.1097/PAS.0000000000001150.
The putative tumor suppressor, miR-199a, regulated by Snail, modulates clear cell renal cell carcinoma aggressiveness by repressing ROCK1.
Zhang X, Li P, Ding Z, Wang H, Wang J, Han L
Onco Targets Ther. 2018; 11:103-112.
PMID: 29343969
PMC: 5749572.
DOI: 10.2147/OTT.S147184.
Identification of clear cell renal cell carcinoma and oncocytoma using a three-gene promoter methylation panel.
Pires-Luis A, Costa-Pinheiro P, Ferreira M, Antunes L, Lobo F, Oliveira J
J Transl Med. 2017; 15(1):149.
PMID: 28662726
PMC: 5492907.
DOI: 10.1186/s12967-017-1248-y.
Moving beyond vascular endothelial growth factor-targeted therapy in renal cell cancer: latest evidence and therapeutic implications.
Tsao C, Liaw B, He C, Galsky M, Sfakianos J, Oh W
Ther Adv Med Oncol. 2017; 9(4):287-298.
PMID: 28491148
PMC: 5405995.
DOI: 10.1177/1758834016687261.
Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
Shi L, Xiao L, Heng B, Mo S, Chen W, Su Z
Int Urol Nephrol. 2017; 49(7):1165-1176.
PMID: 28349447
DOI: 10.1007/s11255-017-1578-y.
High fidelity of driver chromosomal alterations among primary and metastatic renal cell carcinomas: implications for tumor clonal evolution and treatment.
Kouba E, Eble J, Simper N, Grignon D, Wang M, Zhang S
Mod Pathol. 2016; 29(11):1347-1357.
PMID: 27469331
DOI: 10.1038/modpathol.2016.133.
Unlike in clear cell renal cell carcinoma, KRAS is not mutated in multilocular cystic clear cell renal cell neoplasm of low potential.
Raspollini M, Castiglione F, Martignoni G, Cheng L, Montironi R, Lopez-Beltran A
Virchows Arch. 2015; 467(6):687-693.
PMID: 26438300
DOI: 10.1007/s00428-015-1859-8.
Papillary renal cell carcinoma: a clinicopathological and whole-genome exon sequencing study.
Liu K, Ren Y, Pang L, Qi Y, Jia W, Tao L
Int J Clin Exp Pathol. 2015; 8(7):8311-35.
PMID: 26339402
PMC: 4555730.
Metanephric adenoma: the utility of immunohistochemical and cytogenetic analyses in differential diagnosis, including solid variant papillary renal cell carcinoma and epithelial-predominant nephroblastoma.
Kinney S, Eble J, Hes O, Williamson S, Grignon D, Wang M
Mod Pathol. 2015; 28(9):1236-48.
PMID: 26248896
DOI: 10.1038/modpathol.2015.81.
IMA901: a multi-peptide cancer vaccine for treatment of renal cell cancer.
Kirner A, Mayer-Mokler A, Reinhardt C
Hum Vaccin Immunother. 2015; 10(11):3179-89.
PMID: 25625928
PMC: 4514142.
DOI: 10.4161/21645515.2014.983857.
Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.
Yang J, Yang J, Gao Y, Zhao L, Liu L, Qin Y
PLoS One. 2014; 9(11):e111364.
PMID: 25368985
PMC: 4219714.
DOI: 10.1371/journal.pone.0111364.